BiotechTube
Home/Evox Therapeutics/Douglas Treco, PhD
DT

Douglas Treco, PhD

Board Member

Evox Therapeutics

Therapeutic Areas

Neurodegenerative DiseasesNeurodevelopmental Disorders

Evox Therapeutics Pipeline

DrugIndicationPhase
ExoEdit® for Rett SyndromeRett SyndromePre-clinical

Leadership Team at Evox Therapeutics

PL
Per Lundin, PhD
Co-founder & Chief Executive Officer
View full Evox Therapeutics profile